T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$1.3B |
| 2 |
American Airlines Group
AAL
|
+$853M |
| 3 |
Intuitive Surgical
ISRG
|
+$816M |
| 4 |
Morgan Stanley
MS
|
+$681M |
| 5 |
Wynn Resorts
WYNN
|
+$622M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.4B |
| 2 |
eBay
EBAY
|
+$763M |
| 3 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$760M |
| 4 |
Broadcom
AVGO
|
+$757M |
| 5 |
US Bancorp
USB
|
+$686M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.64% |
| 2 | Consumer Discretionary | 13.46% |
| 3 | Financials | 12.79% |
| 4 | Industrials | 12.13% |
| 5 | Technology | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Autohome
ATHM
$2.65B
| $40.4M | 0.01% |
1,173,323
+951,223
| +428% | +$32.5M |
|
|
DENN
927
DELISTED
Denny's
DENN
| $40.3M | 0.01% |
6,179,368
+213,992
| +4% | +$1.4M |
|
|
HEES
928
DELISTED
H&E Equipment Services
HEES
| $40.2M | 0.01% |
1,105,010
-699,130
| -39% | -$25.6M |
|
|
LLTC
929
DELISTED
Linear Technology Corp
LLTC
| $40.1M | 0.01% |
852,590
-146,304
| -15% | -$6.78M |
|
|
XXIA
930
DELISTED
Ixia
XXIA
| $40.1M | 0.01% |
3,507,870
+1,150
| +0% | +$14K |
|
931
Applied Industrial Technologies
AIT
$13B
| $39.9M | 0.01% |
786,402
+5,750
| +0.7% | +$278K |
|
932
Comfort Systems
FIX
$61.2B
| $39.8M | 0.01% |
2,520,451
+176,907
| +8% | +$2.77M |
|
933
Astec Industries
ASTE
$994M
| $39.8M | 0.01% |
906,790
+15,950
| +2% | +$657K |
|
934
SLM Corp
SLM
$5.26B
| $39.3M | 0.01% |
4,723,768
-10,850,513
| -70% | -$95.6M |
|
|
GIFI
935
DELISTED
Gulf Island Fabrication
GIFI
| $39.2M | 0.01% |
1,823,480
+23,450
| +1% | +$488K |
|
|
CSS
936
DELISTED
CSS Industries, Inc.
CSS
| $39M | 0.01% |
1,478,810
+2,200
| +0.1% | +$55.5K |
|
|
CTRA
937
DELISTED
Coterra Energy
CTRA
| $39M | 0.01% |
1,141,795
-44,300
| -4% | -$1.59M |
|
938
Modine Manufacturing
MOD
$10.6B
| $39M | 0.01% |
2,474,950
-53,600
| -2% | -$825K |
|
|
CCI.PRA
939
DELISTED
Crown Castle International Corp.
CCI.PRA
| $38.9M | 0.01% |
386,127
+2,100
| +0.5% | +$215K |
|
940
RingCentral
RNG
$5.25B
| $38.9M | 0.01% |
2,570,718
+847,546
| +49% | +$12.3M |
|
941
PDF Solutions
PDFS
$2.19B
| $38.7M | 0.01% |
1,825,301
-12,270
| -0.7% | -$235K |
|
942
Kratos Defense & Security Solutions
KTOS
$11.8B
| $38.7M | 0.01% |
4,961,742
+7,000
| +0.1% | +$54.3K |
|
|
SFE
943
DELISTED
Safeguard Scientifics, Inc.
SFE
| $38.7M | 0.01% |
1,860,063
-29,400
| -2% | -$591K |
|
944
Kinder Morgan
KMI
$71.4B
| $38.6M | 0.01% |
1,065,492
+451
| +0% | +$15.2K |
|
|
RSTI
945
DELISTED
Rofin-Sinar Technologies Inc
RSTI
| $38.2M | 0.01% |
1,588,490
+53,848
| +4% | +$1.25M |
|
946
Supernus Pharmaceuticals
SUPN
$2.78B
| $37.5M | 0.01% |
3,428,890
-757,661
| -18% | -$6.75M |
|
|
MWIV
947
DELISTED
MWI VETERINARY SUPPLY, INC.
MWIV
| $37.4M | 0.01% |
263,600
+4,000
| +2% | +$587K |
|
948
Amphenol
APH
$204B
| $37.4M | 0.01% |
3,106,840
-4,800
| -0.2% | -$57.2K |
|
949
M/I Homes
MHO
$3.82B
| $37.3M | 0.01% |
1,534,860
+1,900
| +0.1% | +$43.2K |
|
950
Corpay
CPAY
$26.9B
| $37.2M | 0.01% |
282,435
-19,900
| -7% | -$2.43M |
|
Similar funds
T. Rowe Price Associates's Q2 2014 Portfolio in Review
As of Q2 2014, T. Rowe Price Associates held 2,596 positions worth $463B, up 3.9% from $445B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q2 2014 filing shows 97 new, 1,091 increased, 793 reduced and 67 closed positions. Its largest new stake was Teva Pharmaceuticals: 4,638,481 shares worth $243M. The largest sale was Procter & Gamble, an estimated $1.4B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2014 buy was Teva Pharmaceuticals: 4,638,481 shares worth $243M.
- T. Rowe Price Associates added most to Allergan Inc in Q2 2014, an estimated $1.3B increase.
- T. Rowe Price Associates's biggest Q2 2014 reduction was Procter & Gamble, cutting an estimated $1.4B.
- T. Rowe Price Associates fully exited Santander in Q2 2014, selling an estimated $134M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $463B portfolio in Q2 2014.
- T. Rowe Price Associates opened 97 new positions and closed 67 in Q2 2014.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $463B.
Based on T. Rowe Price Associates's 13F filing for Q2 2014, filed 14 Aug 2014.